Rivaroxaban with or without aspirin for prevention of cardiovascular disease
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- August 2018
has subject area
- 1103 Clinical Sciences (FoR)
- Aspirin (MeSH)
- Blood Coagulation (MeSH)
- Cardiovascular Diseases (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Clinical Decision-Making (MeSH)
- Evidence-Based Medicine (MeSH)
- Factor Xa Inhibitors (MeSH)
- Fibrinolytic Agents (MeSH)
- Hemorrhage (MeSH)
- Humans (MeSH)
- Platelet Activation (MeSH)
- Platelet Aggregation Inhibitors (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Risk Assessment (MeSH)
- Risk Factors (MeSH)
- Rivaroxaban (MeSH)
- Thrombosis (MeSH)
- Treatment Outcome (MeSH)
published in
- Coronary Artery Disease Journal